Concepedia

Author

Geralyn Caliendo

Montefiore Medical Center

Also Known As

G Caliendo, G. Caliendo, Geralyn Caliendo

14

Publications

285

Citations

8

H-Index

9

Concepts

All Affiliations

Montefiore Medical CenterAlbert Einstein College of Medicine
GC

About

Geralyn Caliendo is an author at Montefiore Medical Center specializing in oncology, medicine, and neuro-oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

30

2

Neurology

1

1

11

3

Pharmacology

1

1

11

4

Head And Neck Cancer

1

1

11

5

Neuro-oncology

1

1

11

Geralyn Caliendo

×

8

Publications

266

Citations

8

H-Index

YearCitations

Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study.

Janice P. Dutcher, Richard I. Fisher, Geoffrey R. Weiss,

PubMed

1997

77

Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha

Joseph A. Sparano, Janice P. Dutcher, Ronald Kaleya,

Cancer

1991

52

Phase I Study of High-Dose Continuous-Infusion Recombinant Interleukin-2 and Autologous Lymphokine-Activated Killer Cells in Patients With Metastatic or Unresectable Malignant Melanoma and Renal Cell Carcinoma

Ellen R. Gaynor, Geoffrey R. Weiss, Kim Margolin,

JNCI Journal of the National Cancer Institute

1990

47

Polyethylene glycolated interleukin‐2 as maintenance therapy for acute myelogenous leukemia in second remission

Peter H. Wiernik, Janice P. Dutcher, Mary B. Todd,

American Journal of Hematology

1994

21

Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2

Euan Walpole, J. P. Dutcher, JA Sparano,

Journal of Immunotherapy

1993

21

Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma

Jingjing Wu, Geralyn Caliendo, Xiao Hu,

Medical Oncology

1998

19

A distinct coagulopathy associated with Interleukin‐2 therapy

Leslie Oleksowicz, Margery Strack, Janice P. Dutcher,

British Journal of Haematology

1994

18

Phase II trial of merbarone in patients with malignant brain tumors

Ummekalsoom R. Malik, Janice P. Dutcher, Geralyn Caliendo,

Medical Oncology

1997

11

Page 1